Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Behold Ventures in the fundraising of Behold Ventures’ first-time fund
Mandate

Vinge has advised Behold Ventures in the fundraising of Behold Ventures’ first-time fund

July 10, 2025

Behold Ventures held its final closing on 27 June 2025, thereby securing investor commitments to its first-time fund amounting to approximately SEK 550 million from an international investor base, comprising the European Investment Fund (EIF), among others.

Behold Ventures is a niche Swedish venture capital investor focused on investments in early-stage gaming startups. Behold Ventures has at the time of final closing made investments in 18 startups in the gaming industry.

 

Vinge’s team primarily consisted of Mattias Schömer, Martin Cronsioe, Tobias Onegård Karlsson, Mikaela Reinhammar, Ulf Nilsson, Emelie Svanberg, Morgan Ödman, Jenny Tolander, Jonna Bondemark, Erik Kochbati, Saga Meyer Viklund, Sara Link, Marcus Svärd and Emelie Zingmark.

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

 Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

 Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025